Concepedia

Systemic Bioavailability

Systemic Bioavailability is a pharmacokinetic parameter that quantifies the fraction of an administered drug dose that reaches the systemic circulation unchanged and becomes available for distribution to target sites following non-intravenous administration, as distinguished from local or first-pass metabolism.

411

Publications

25.4K

Citations

2K

Authors

658

Institutions

Publications per year

2017–2026

89

Parents

Publications

411

HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS

Thomas Walle, Faye Hsieh, Mark H. DeLegge et al. · Drug Metabolism and Disposition · 2004 · 1.8K citations

, , +15

Dose escalation of a curcuminoid formulation

Christopher D. Lao, Mack T. Ruffin, Daniel P. Normolle et al. · BMC Complementary and Alternative Medicine · 2006 · 1.4K citations · Full text

, , +13

Large Porous Particles for Pulmonary Drug Delivery

David A. Edwards, Justin Hanes, Giovanni Caponetti et al. · Science · 1997 · 1.2K citations

, , +17

Metabolism and Kinetics of Bisphenol A in Humans at Low Doses Following Oral Administration

Wolfgang Völkel, Thomas Colnot, György A. Csanády et al. · Chemical Research in Toxicology · 2002 · 995 citations

, , +14

A Comparison of Budesonide with Prednisolone for Active Crohn's Disease

Paul Rutgeerts, Robert Löfberg, H Malchow et al. · New England Journal of Medicine · 1994 · 603 citations · Full text

, , +16

1–5 of 411

Authors

2K

  1. HC
    Henry Chrystyn

    University of Bradford, United Kingdom

    9 publications · 296 citations

    9

    h-index

  2. BJ
    Brian J. Lipworth

    Ninewells Hospital, United Kingdom

    6 publications · 202 citations

    6

    h-index

  3. MA
    M. Atef

    Cairo University, Egypt

    5 publications · 114 citations

    5

    h-index

  4. MG
    Mark G. Papich

    North Carolina State University, United States

    4 publications · 132 citations

    4

    h-index

  5. PD
    Prasad Dandawate

    The University of Kansas Cancer Center, United States

    3 publications · 312 citations

    3

    h-index

1–5 of 2K

Institutions

658

  1. Cairo University

    Giza, Egypt

    13 h-index

    33 publications

    936 citations

  2. University of Bradford

    Bradford, United Kingdom

    8 h-index

    17 publications

    593 citations

  3. AstraZeneca (Sweden)

    Södertälje, Sweden

    7 h-index

    23 publications

    2.5K citations

  4. Beni-Suef University

    Banī Suwayf, Egypt

    7 h-index

    17 publications

    671 citations

  5. University of Dundee

    Dundee, United Kingdom

    6 h-index

    29 publications

    983 citations

  6. University of Arizona

    Tucson, United States

    6 h-index

    17 publications

    646 citations

  7. Novartis (Switzerland)

    Basel, Switzerland

    6 h-index

    20 publications

    838 citations

  8. North Carolina State University

    Raleigh, United States

    5 h-index

    23 publications

    537 citations

1–8 of 658

Venues

  1. PubMed

    Repository · 36 publications · 2.3K citations

    21

    h-index

  2. British Journal of Clinical Pharmacology

    BJCP · 22 publications · 893 citations

    18

    h-index

  3. The Journal of Clinical Pharmacology

    13 publications · 667 citations

    13

    h-index

  4. Clinical Pharmacology & Therapeutics

    CPT · 10 publications · 590 citations

    10

    h-index

  5. Biopharmaceutics & Drug Disposition

    11 publications · 288 citations

    10

    h-index

1–5